FDA’s emphasis on improving and ensuring drug quality has received another strong endorsement demonstrating its priority status within the agency.
Center for Drug Evaluation and Research Director Janet Woodcock decided to delegate duties to others in order to devote more time to a new
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?